Summary
Human sera were tested for insulin antibodies by fluid and solid phase assays. Radioimmune titres determined with 125-I Tyr A14 insulin were not correlated with those obtained using insulin coated microplates and enzyme linked immunodetection (n=60). Several reasons for this lack of correlation were found. Iodine substitution on the A14 residue of insulin may significantly alter the avidity of some insulin antibodies for their ligand; hence, disclosing a heretofore unsuspected pitfall for antibody determination by radio-immunoassay. Specificity for bovine insulin was easily demonstrable in fluid phase by comparing the binding of monoiodinated bovine, porcine and human insulin. By contrast, in solid phase assay, titres obtained with microplates coated with bovine or human insulin were almost equal, regardless of the serum specificity for bovine insulin. This lack of specificity of the solid phase assay is not due to denaturation or unavailability of the bovine specific epitope because: bovine specificity could be demonstrated by competitive assay, after preincubation of the serum with insulin of the different species; and, coating with crosslinked insulin dimers or oligomers instead of monomers did not unmask bovine specificity. It is concluded that radioimmune methods are best suited to study specificity but may be biased by the presence of the radioiodine label whereas solid phase assay detects low avidity antibodies with great efficiency but is less appropriate to study specificity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Banting FG, Franks WR, Gairns S (1938) Physiological studies in metrazole shock. VII. Anti-insulin activity of insulin treated patients. Am J Psychol 95: 562–564
Berson SA, Yalow RS (1959) Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 38: 1996–2016
Christiansen AH (1970) A new method for determination of insulin-binding immuno-globulins in insulin-treated diabetic patients. Horm Metab Res 2: 187–188
Jorgensen KH, Larsen UD (1980) Homogeneous mono-125I-insulins: preparation and characterisation of mono-125I-(Tyr A14)-and mono-125I-(Tyr A19)-insulin. Diabetologia 19: 546–554
Herbert V, Lau KS, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375–1384
Dixon K (1974) Measurement of antibodies to insulin in serum. Clin Chem 20: 1275–1281
Reeves WG, Kelly U (1980) An immunochemical method for the quantitation of insulin antibodies. J Immunol Methods 34: 329–338
Desbuquois B, Aurbach GB (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33: 732–738
Kurtz AB, Nabarro JDN (1980) Circulating insulin-binding antibodies. Diabetologia 19: 329–334
Engvall E, Perlmann P (1972) Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzymelabeled anti-immunoglobulin in antigen coated tubes. J Immunol 109: 129–135
Nell LJ, Virta VJ, Thomas JW (1985) Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody. Diabetes 34: 60–66
Wilkin T, Nicholson S; Casey C (1985) A micro enzyme-linked immunosorbent assay for insulin antibodies in serum. J Immunol Methods 76: 185–194
Hirata Y, Ishizu H, Ouchi N, Motomura S, Abe M, Kara Y, Wakasugi H, Takahashi I, Sakano H, Tanaka M, Kawano H, Kanesaki T (1970) Insulin autoimmunity in a case with spontaneous hypoglycemia. Jap J Diabetes 13: 312–319
Ichihara K, Shima K, Saito Y, Nonaka K, Tarui S, Nishikawa M (1977) Mechanism of hypoglycemia observed in a patient with insulin autoimmune syndrome. Diabetes 26: 500–506
Goldman J, Baldwin D, Rubenstein AH, Klink DD, Blackard WG, Fisher LK, Roe TF, Schnure JJ (1979) Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Invest 63: 1050–1059
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339
Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EAM, Bottazzo GF (1986) Insulin autoantibodies in the prediabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia 29: 339–342
Wilkin T, Armitage M, Casey C, Pyke DA, Hoskins PJ, Rodier M, Diaz JL, Leslie RDG (1985) Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet I: 480–482
Arslanian SA, Becker DJ, Rabin B, Atchison R, Eberhardt M, Cavender D, Dorman J, Drash AL (1985) Correlates of insulinantibodies in newly diagnosed children with insulin-dependent diabetes prior to insulin therapy. Diabetes 34: 926–930
Atkinson MA, MacLaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP (1986) Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 35: 894–898
Wilkin T, Palmer J, Bonifacio E, Diaz JL, Kruse V (1987) First international workshop on the standardisation of insulin autoantibodies. Diabetologia 30: 676–677
Markussen J, Larsen UD (1980) The application of HPLC to the analysis of radio-iodinated tracers of glucagon and insulin. In: Brandenburg D, Wollmer A, Gattner HG (eds) Insulin, chemistry, structure and function of insulin and related hormones. De Gruyter, Berlin, pp 161–168
Sodoyez JC, Sodoyez-Goffaux F, Guillaume M, Merchie G (1983) Insulin metabolism in normal rats and human: external detection by a scintillation camera. Science 219: 865–867
Schmitt EW (1978) Verbesserte Darstellung von Des-alanyl B30-insulin. Hoppe-Seyler's Physiol Chem 359: 799–802
Brandenburg D (1972) Preparation of NA1, NB29 adipoylinsulin, an intramolecularly crosslinked derivative of beef insulin. Hoppe-Seyler's Z Physiol Chem 353: 869–873
Sklenar I, Wilkin TJ, Diaz JL, Erb P, Keller U (1987) Spontaneous hypoglycemia associated with autoimmunity specific to human insulin. Diabetes Care 10: 152–159
Koch M, François-Gerard C, Sodoyez-Goffaux F, Sodoyez JC (1986) Semi-quantitative assessment of antiinsulin total IgG and IgG subclasses in insulin-immunised patients using a highly sensitive immunochemical micromethod. Diabetologia 29: 720–726
Sodoyez JC, Sodoyez-Goffaux F, Goff MM, Zimmerman AE, Arquilla ER (1975) 127-1 or carrier-free 125-1 monoiodoinsulin. Preparation, physical, immunological and biological properties and susceptibility to “insulinase” degradation. J Biol Chem 250: 4268–4277
Gliemann J, Sonne O, Linde S, Hansen B (1979) Biological potency and binding affinity of monoiodoinsulin with iodine in tyrosine A14 or tyrosine A19. Biochem Biophys Res Commun 87: 1183–1190
Frank BH, Peavy DE, Hooker CS, Duckworth WC (1983) Receptor binding properties of monoiodotyrosyl insulin isomers purified by high performance liquid chromatography. Diabetes 32: 705–711
Killshaw PI, McEwan FJ, Backer KC, Cant AJ (1986) Studies on the specificity of antibodies to ovalbumin in normal human serum. Technical considerations in the use of ELISA methods. Clin Exp Immunol 66: 481–489
Suter M, Butler JE (1986) The immunochemistry of sandwich ELISA II. A novel system prevents the denaturation of capture antibodies. Immunol Lett 13: 313–319
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sodoyez-Goffaux, F., Koch, M., Dozio, N. et al. Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodies. Diabetologia 31, 694–702 (1988). https://doi.org/10.1007/BF00278754
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00278754